antistaphylococcal bacteriophage

Stafal® is a dermal solution containing polyvalent phage particles, operating on a broad range of strains of Staphylococcus aureus, including MRSA strains. It is also shown to be effective for other species of the genus Staphylococcus.

Stafal is registered in the Slovak Republic.

In The Czech Republic Stafal is available under The Specific Treatment Program (SpLP) in Immuno Allergology, Otorhinolaryngology and Surgery.

The content of this web site is intended solely for professional health community. By clicking "I agree" I declare that I am a member.

I agree